# Combined Radiotherapy and Radiofrequency Ablation for Hepatocellular Carcinoma

> **NCT04202523** · PHASE3 · UNKNOWN · sponsor: **Guangxi Medical University** · enrollment: 50 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **RADIATION:** Radiofrequency ablation
- **DEVICE:** IMRT & SBRT

## Key facts

- **NCT ID:** NCT04202523
- **Lead sponsor:** Guangxi Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12-01
- **Primary completion:** 2020-12-01
- **Final completion:** 2020-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2019-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04202523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04202523, "Combined Radiotherapy and Radiofrequency Ablation for Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04202523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*